Preclinical hemolysis testing – from whole blood or plasma
Hemolysis is an undesirable effect that can be caused by drug treatments or mechanical forces. It is important (and recommended) to test for hemolysis when developing a novel treatment or device that comes into contact with blood.
Discover the power of Biotect Services’ hemolysis assay, designed for preclinical studies.
Whether you’re working with whole blood or plasma, we deliver accurate results following the Harboe method in just 48 hours for up to 100 samples, helping you streamline your research process.
You can expect a Certificate of Analysis with each sample’s hemoglobin content reported in mg/dL along with a spectral profile.